European skills shortages hit cancer equipment market
This article was originally published in Clinica
State funding restrictions are not the only factor discouraging European hospitals from purchasing expensive medical devices. A general lack of qualified staff to operate much-needed high-technology cancer equipment is creating an equally difficult challenge, according to a feature in the UK's Guardian.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.